Publication: Methylcobalamin as an Adjuvant Medication in Conservative Treatment of Lumbar Spinal Stenosis
4
Issued Date
2000-08-01
Resource Type
ISSN
01252208
Other identifier(s)
2-s2.0-0034242280
Rights
Mahidol University
Rights Holder(s)
SCOPUS
Bibliographic Citation
Journal of the Medical Association of Thailand. Vol.83, No.8 (2000), 825-831
Suggested Citation
Waraporn Waikakul, Saranatra Waikakul Methylcobalamin as an Adjuvant Medication in Conservative Treatment of Lumbar Spinal Stenosis. Journal of the Medical Association of Thailand. Vol.83, No.8 (2000), 825-831. Retrieved from: https://repository.li.mahidol.ac.th/handle/123456789/26199
Research Projects
Organizational Units
Authors
Journal Issue
Thesis
Title
Methylcobalamin as an Adjuvant Medication in Conservative Treatment of Lumbar Spinal Stenosis
Author(s)
Other Contributor(s)
Abstract
To find out the clinical effects of methylcobalamin on the conservative treatment of degenerative lumbar spinal stenosis, the study was carried out as a control single blind trial with 2 year follow-up in 152 patients, 68 males and 84 females, whose ages ranged from 55 to 85 years, average 67 ± 18.1 years. They were randomly allocated into 2 groups, the control group, 82 patients, and the methylcobalamin group, 70 patients. All had classical history, and physical and radiographic findings which confirmed the diagnosis of spinal stenosis. Conventional management, including patient education, physical therapy and medication, were carried out in every patient and in addition methylcobalamin 0.5 mg was given orally three times a day in the methylcobalamin group for 6 months. All patients were followed up periodically for 2 years. Most of the patients in both groups showed improvement but there was no significant difference between the 2 groups in terms of pain improvement and neurological signs, except neurogenic claudication distance which was better in the M-group.